STADA Pymepharco recently concluded a nationwide series of scientific seminars in collaboration with leading healthcare experts across various fields, including management, academia, and clinical practice. The initiative aimed to provide updated knowledge, share practical treatment solutions, and discuss research findings with healthcare professionals through in-person and online sessions. The seminars were hosted on-site and livestreamed to satellite locations throughout Vietnam.
Pymepharco, officially known as STADA Pymepharco, has been a member of the STADA Group (Germany) since 2021. As one of Vietnam’s leading pharmaceutical manufacturers, the company is known for its high-quality, international-certified products at affordable prices. With two EU-GMP certified manufacturing sites in Phu Yen Province, and an annual production capacity of nearly 3 billion units, STADA Pymepharco plays a strategic role in STADA’s global supply chain and is fully equipped to export to European markets.
STADA Pymepharco's product portfolio includes more than 500 Generics and Consumer Healthcare products, among which approximately 80 have been proven bioequivalent to innovator medicines. In recent years, besides offering high-quality, stable, and standardized products at reasonable prices, the company actively engages in collecting feedback and strengthening customer engagement. These interactions support data-driven policy adjustments tailored to the specific needs of different regions – reflecting STADA Pymepharco's sustainable development strategy built on quality and trust.
From May to July 2024, the scientific seminar series for pharmacists, pharmacy owners, and medicine counter operators was successfully held across the country. These sessions were delivered in close collaboration with leading healthcare professionals and focused on updating specialized knowledge, sharing practical insights, and exchanging treatment experiences from major healthcare institutions. The series was hosted at four primary locations – Hanoi, Da Nang, Ho Chi Minh City, and Can Tho – with 22 satellite locations nationwide, drawing over 500 attendees on-site and nearly 2,000 participants online.
Key topics included: Emerging trends in the diagnosis and treatment of angina; Rational use of antibiotics for respiratory infections; and Operational considerations for pharmacies in today’s healthcare landscape. Presenters included doctors, pharmacists and experts from the Da Nang and Ho Chi Minh City Departments of Health, as well as prestigious hospitals and medical facilities such as: Bach Mai Hospital, Viet - Duc Friendship Hospital, Da Nang General Hospital, Cho Ray Hospital, Can Tho Central General Hospital.
During the events, STADA Pymepharco also introduced its latest product offerings to the audiences. Post-event feedback highlighted participants’ satisfaction with the seminar content, practical relevance, and professional organization – praising the sessions for being informative, easy to understand, and well-executed, as well as the professional and enthusiastic organization of the events.
This positive response serves as a strong motivation for STADA Pymepharco to continue developing tailored, impactful educational initiatives that meet the needs of its partners and customers – true to its global purpose of “Caring for People’s Health as a Trusted Partner.”
